Pd0 Complex with the Trost Ligand
FULL PAPER
tal analysis calcd (%) for C8H12O4 (172.07): C 55.81, H 7.02; found: C
55.61, H 7.18.
and the combined organic phases were washed with 1m HCl, saturated
aqueous NaHCO3, and brine, dried (Na2SO4), and concentrated in vacuo.
Purification by column chromatography on silica gel (n-pentane/Et2O,
5:1) gave benzoate 14 (81 mg, 97%) as a colorless oil. HPLC (Chiralpak
IA, n-heptane/iPrOH, 99.9:0.1, flow rate 0.75 mLminÀ1, l=254 nm): tR
(ent-14)=18.43 min, tR (14)=20.70 min, ꢀ99% ee; [a]D =À49.5 (c=1.0
in CH2Cl2); 1H NMR (400 MHz, CDCl3): d=2.04 (m, 4H), 3.81 (s, 3H),
5.15 (m, 1H), 5.50 (m, 1H), 6.04 (qd, J=11.0, 3.0 Hz, 2H), 7,44 (t, J=
8.0 Hz, 2H), 7.56 (t, J=7.4 Hz, 1H), 8.05 ppm (d, J=6.9 Hz, 2H);
13C NMR (100 MHz, CDCl3): d=24.9 (u), 25.1 (u), 54.8 (d), 67.7 (d), 71.1
(d), 128.3 (d), 129.5 (d), 129.6 (d), 130.2 (u), 130.9 (d), 133.0 (d), 155.3
(u), 165.9 ppm (u); IR (capillary): n˜ =3421 (w), 2963 (m), 1746 (vs), 1717
(vs), 1601 (v), 1584 (w), 1541 (w), 1445 (m), 1398 (w), 1343 (w), 1315 (w),
1264 (vs), 1212 (w), 1176 (w), 1110 (s), 1071 (w), 1052 (w), 1012 (s), 941
(m), 924 (m), 792 (m), 755 cmÀ1 (w); MS (CI, CH4): m/z (%): 276 (1)
[M+], 201 (100), 155 (76), 133 (3), 123 (41), 111 (6), 105 (74), 91 (2), 79
(35), 77 (38); elemental analysis calcd (%) for C15H16O5 (276.10): C
65.21, H 5.84; found: C 65.02, H 5.79.
Carbonate 12b: A Schlenk flask was successively charged with [Pd2-
ACHTUNGTRENNUNG(dba)3]·CHCl3 (83 mg, 0.08 mmol), ligand 2 (110 mg, 0.16 mmol), KHCO3
(280 mg, 2.8 mmol), and degassed CH2Cl2 (9 mL). Then the mixture was
stirred at room temperature for 15 min. After the mixture was cooled to
08C, it was treated with degassed water (1 mL) and carbonate 5b
(460 mg, 2 mmol) and the mixture was rapidly stirred at 08C for 24 h.
Then the mixture was poured into cyclohexane/EtOAc (1:1; 200 mL) and
filtered through a plug of silica gel (0.0040–0.063 mm; 3ꢁ2 cm). The or-
ganic phase was dried (MgSO4) and concentrated in vacuo. Purification
by chromatography on silica gel (cyclohexane/EtOAc, 7:2) afforded car-
bonate 12b (258 mg, 92%) of 96% ee (determined by HPLC after hy-
drolysis to 13b and benzoylation to 15) as a colorless oil. [a]D =+5.0 (c=
11.0 in CH2Cl2); 1H NMR (300 MHz, CDCl3): d=1.94 (m, 1H), 2.10 (m,
2H), 2.30 (m, 1H), 4.93 (m, 1H), 5.03 (m, 1H), 5.79 (dqtd, J=10.1, 1.7,
0.5 Hz, 1H), 6.24 ppm (dtd, J=10.1, 4.0, 0.8 Hz, 1H); 13C NMR
(75 MHz, CDCl3): d=19.5 (u), 21.2 (u), 72.2 (d), 74.9 (d), 121.3 (d), 135.3
(d), 155.0 ppm (u); IR (capillary): n˜ =3040 (w), 2957 (vs), 2930 (vs), 2859
(s), 1928 (w), 1801 (vs), 1726 (vs), 1652 (w), 1600 (w), 1550 (w), 1459
(m), 1377 (m), 1354 (m), 1280 (s), 1203 (m), 1160 (vs), 1077 (s), 1045
(vs), 1022 (vs), 978 (w), 961 (w), 928 (w), 875 (w), 852 (w), 773 cmÀ1 (m);
MS (CI, CH4): m/z (%): 141 (49) [M++1], 97 (19), 79 (100), 68 (3), 63
(6); elemental analysis calcd (%) for C7H8O3 (140.05): C 59.99, H 5.75;
found: C 59.74, H 5.50.
Diol 13b: K2CO3 (181 mg, 1.28 mmol) was added portionwise to a solu-
tion of carbonate 12b (30 mg, 0.21 mmol) in MeOH (5 mL) and the mix-
ture was stirred at room temperature for 1 h. The mixture was concen-
trated in vacuo, the residue was dissolved in water (5 mL), and the solu-
tion was extracted with EtOAc (5ꢁ10 mL). The combined organic
phases were dried (MgSO4) and concentrated in vacuo, which gave diol
13b (24.2 mg, 99%) as a slightly yellow oil. The thus-obtained diol was
pure enough for benzoylation. Purification by column chromatography
(cyclohexane/EtOAc, 1:9) gave diol 13b (24 mg, 98%) of 96% ee (deter-
mined by HPLC after benzoylation to 15) as a colorless oil. [a]D =À172.0
Carbonate 12c: A Schlenk flask was successively charged with [Pd2-
ACHTUNGTRENNUNG(dba)3]·CHCl3 (70 mg, 0.067 mmol), ligand 2 (97 mg, 0.14 mmol), KHCO3
(127 mg, 1.26 mmol), and degassed CH2Cl2 (18 mL). After the mixture
was stirred at room temperature for 15 min, it was cooled to 08C and suc-
cessively treated with degassed water (2 mL) and carbonate 5c (200 mg,
0.82 mmol) in degassed CH2Cl2 (18 mL). After the mixture was rapidly
stirred at 08C for 24 h, it was poured into cyclohexane/EtOAc (1:1)
(200 mL) and the mixture was filtered through a plug of silica gel
(0.0040–0.063 mm; 3ꢁ2 cm). The organic phase was dried (MgSO4) and
concentrated in vacuo. Purification by chromatography on silica gel (cy-
clohexane/EtOAc, 7:2) afforded carbonate 12c (20 mg, 16%) of 91% ee
(Lipodex-gamma, H2, tR (12c)=94.1 min, tR (ent-12c)=94.7 min) as a
colorless oil and biscarbonate 5c (164 mg, 82%). [a]D =À30.0 (c=0.5 in
CH2Cl2); 1H NMR (400 MHz, CDCl3): d=1.53–2.32 (m, 6H), 4.77–4.85
(m, 1H), 5.40 (m, 1H), 5.61–5.66 (m, 1H), 5.81–5.89 ppm (m, 1H);
13C NMR (100 MHz, CDCl3): d=18.4 (u), 27.5 (u), 27.6 (u), 77.7 (d), 78.3
(d), 123.5 (d), 131.3 (d), 154.1 ppm (u); IR (capillary): n˜ =3569 (w), 2943
(m), 2870 (w), 1786 (vs), 1658 (w), 1545 (w), 1457 (m) 1362 (s), 1263 (w),
1166 (vs), 1055 (vs), 881 (w), 841 (m), 770 cmÀ1 (m); MS (EI, 70 eV): m/z
(%): 155 (10), 111 (1), 109 (4), 92 (45), 81 (28), 68 (86), 67 (100), 54 (51);
elemental analysis calcd (%) for C8H10O3 (154.16): C 62.33, H 6.54;
found: C 62.54, H 6.41.
1
(c=1 in CH2Cl2); H NMR (400 MHz, CDCl3): d=1.65 (m, 1H), 1.72 (m,
1H), 1.96 (m, 1H), 2.14 (m, 1H), 3.56 (brs, 2H), 3.75 (dt, J=9.3, 3.8 Hz,
1H), 4.05 (brs, 1H), 5.64 (dqt, J=10.2, 1.9 Hz, 1H), 5.78 ppm (dtd, J=
10.2, 3.7, 0.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=23.7 (u), 25.8 (u),
66.5 (d), 68.9 (d), 126.9 (d), 131.0 ppm (d); IR (capillary): n˜ =3773 (vs),
3027 (m), 2922 (s), 2655 (w), 1650 (m), 1434 (s), 1404 (s), 1323 (w), 1252
(m), 1226 (m), 1193 (w), 1151 (m), 1080 (vs), 995 (s), 972 (m), 914 (m),
878 (w), 862 (w), 824 (m), 754 cmÀ1 (s); MS (EI, 70 eV): m/z (%): 114 (1)
[M+], 97 (2), 79 (1), 70 (100), 67 (4), 57 (2), 55 (9), 53 (4), 51 (4), 45 (2);
elemental analysis calcd (%) for C6H10O2 (114.07): C 63.14, H 8.83;
found: C 63.08, H 8.74.
Diol 13c: A mixture of carbonate 12c (50 mg, 0.32 mmol) of 68% ee and
K2CO3 (200 mg, 1.45 mmol) in MeOH (5 mL) was stirred at room tem-
perature for 16 h. Then the mixture was concentrated in vacuo, the resi-
due was dissolved in water (5 mL), and the solution was extracted with
EtOAc (4ꢁ10 mL). The combined organic phases were dried (MgSO4)
and concentrated in vacuo. Purification by column chromatography (cy-
clohexane/EtOAc, 1:9) gave diol 13c (20 mg, 45%). [a]D =À65.0 (c=
0.95 in CHCl3); 1H NMR (400 MHz, CDCl3): d=1.45–1.70 (m, 2H), 1.80
(m, 1H), 1.90–2.15 (m, 2H), 2.23 (m, 1H), 2.55 (brs, 2H), 3.95 (m, 1H),
4.45 (dd, J=1.7, 1.9 Hz, 1H), 5.55 (dqt, J=11.5, 1.9 Hz, 1H), 5.91 ppm
(m, 1H); 13C NMR (100 MHz, CDCl3): d=20.8 (u), 28.5 (u), 33.9 (u),
72.5 (d), 73.9 (d), 131.8 (d), 132.6 ppm (d); IR (capillary): n˜ =3379 (vs),
3027 (m), 2923 (vs), 2677 (w), 1655 (m), 1442 (s), 1385 (m), 1351 (w),
1273 (s), 1171 (w), 1034 (vs), 994 (vs), 942 (m), 905 (m), 872 (m), 833
(m), 771 (m), 729 (w), 674 cmÀ1 (m); MS (ESI, 70 eV): m/z (%): 111 (1)
[M+ÀOH], 92 (100), 67 (6).
Carbonate ent-12c: A Schlenk flask was successively charged with [Pd2-
ACHTUNGTRENNUNG(dba)3]·CHCl3 (156 mg, 0.151 mmol), ligand ent-2 (225 mg, 0.33 mmol),
KHCO3 (255 mg, 2.55 mmol), and degassed CH2Cl2 (15 mL). After the
mixture was stirred at room temperature for 5 min, it was cooled to 08C
and successively treated with degassed water (2.5 mL) and carbonate 5c
(415 mg, 1.70 mmol) in degassed CH2Cl2 (8 mL). After the mixture was
rapidly stirred at 08C for 24 h, it was warmed to room temperature and
stirred for 12 h under air. The organic phase was separated from the
aqueous phase with a syringe and treated with diethyl ether (360 mL).
The suspension was centrifuged and the solid was washed with diethyl
ether. The combined organic phases were dried (MgSO4) and concentrat-
ed in vacuo. Purification by chromatography on silica gel (cyclohexane/
EtOAc, 7:2) gave carbonate ent-12c (102 mg, 39%) of 99% ee as a color-
less oil. [a]D =+35.0 (c=1.2 in CH2Cl2).
Dibenzoate 15: The synthesis of dibenzoate 15 (115 mg, 95%) from diol
13b was performed according to the procedure used for the synthesis of
monobenzoate 14 with the exception that 0.1 equiv of 4-DMAP, 3 equiv
of NEt3, and 2.1 equiv of PhCOCl were used. Colorless oil; HPLC (Chir-
alpak IA, n-heptane/iPrOH=99.2:0.8, flow rate 0.75 mLminÀ1
, l=
254 nm): tR (ent-15)=31.17 min, tR (15)=32.31 min, 96% ee, [a]D =
À118.0 (c=1.0 in CH2Cl2); 1H NMR (300 MHz, CDCl3): d=1.93 (m,
1H), 2.06–2.35 (m, 3H), 5.36 (dt, J=10.1, 3.5 Hz, 1H), 5.71 (m, 1H), 5.77
(m, 1H), 5.98 (dt, J=9.6, 3.2 Hz, 1H), 7.24 (t, J=7.9 Hz, 2H), 7.30 (t, J=
8.2 Hz, 1H), 7.40 (m, 2H), 7.85 (d, J=8.4 Hz, 2H), 7.93 ppm (d, J=
8.4 Hz, 2H); 13C NMR (75 MHz, CDCl3): d=23.6 (u), 24.0 (u), 67.4 (d),
70.3 (d), 123.5 (d), 128.3 (d), 128.4 (d), 129.6 (d), 129.7 (d), 130.3 (u),
130.4 (u), 132.9 (d), 133.0 (d), 133.1 (d), 165.8 (u), 166.0 ppm (u); IR (ca-
Benzoate 14: Alcohol 6b (52 mg, 0.3 mmol) and 4-DMAP (4-DMAP=4-
dimethylaminopyridine; 1.8 mg, 0.015 mmol) were dissolved in CH2Cl2
(2 mL) and the solution was cooled to 08C. The mixture was successively
treated with NEt3 (0.06 mL, 0.45 mmol) and PhCOCl (0.037 mL,
0.315 mmol). Then the cooling bath was removed, and after the mixture
was stirred for 2 h, it was poured onto a mixture of ice and saturated
aqueous NaHCO3. The mixture was extracted with CH2Cl2 (3ꢁ10 mL)
Chem. Eur. J. 2010, 16, 2904 – 2915
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2913